Harpoon Therapeutics Company
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Technology:
Biologics, CAR-T therapy
Industry:
PharmTech, Public
Headquarters:
South San Francisco, California, United States
Founded Date:
2015-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
10
Total Funding:
130000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-11-12
Last Funding Type:
Series C
Register and Claim Ownership